Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17953392 | SKIN CONDITIONING COMPOSITION WITH HIGH CONCENTRATION OF UREA TO BOOST THE SKINCARE ACTIVES | Non-Final OA | L'OREAL |
| 18571920 | HIGH-THROUGHPUT PREPARATION OF MICROPARTICLES WITH PULSATILE RELEASE | Non-Final OA | William Marsh Rice University |
| 18514903 | COMPOSITIONS AND METHODS FOR TREATING DEPRESSION AND ANXIETY | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18529500 | USE OF A COMPOSITE MATERIAL | Non-Final OA | Heraeus Medical GmbH |
| 18713856 | HAIR CLEANSING COMPOSITION | Non-Final OA | KAO CORPORATION |
| 18301004 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | Final Rejection | Symrise AG |
| 18009284 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | Non-Final OA | Symrise AG |
| 18344001 | COLORING SOLUTIONS FOR GUM TISSUE COLOR MATCH FOR ZIRCONIA PROSTHESIS | Final Rejection | James R. Glidewell Dental Ceramics, Inc. |
| 18684543 | SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Non-Final OA | Bayer Aktiengesellschaft |
| 18549497 | CHIRAL N-(1,3,4-OXADIAZOLE-2-YL)PHENYL CARBOXYLIC ACID AMIDES AND THEIR USE AS HERBICIDES | Final Rejection | Bayer Aktiengesellschaft |
| 18554687 | METHOD OF INHIBITING FLOWERING OF SUGARCANE | Final Rejection | CORTEVA AGRISCIENCE LLC |
| 17686880 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17309624 | Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them | Non-Final OA | MannKind Corporation |
| 18285570 | SILICA-BASED FORMULATIONS OF THERAPEUTIC OLIOGPEPTIDES AND PEPTIDOMIMETICS | Non-Final OA | Stealth BioTherapeutics Inc. |
| 18709952 | ANTIVIRAL AGENT, ANTIVIRAL PRODUCT, AND ANTIVIRAL TREATMENT LIQUID | Non-Final OA | Kyodo Printing Co., Ltd. |
| 18001936 | NOVEL ANTIBACTERIAL HYDROGELS | Final Rejection | NewSouth Innovations Pty Limited |
| 18549612 | AN OLEOGEL COMPOSITION COMPRISING AN ETHYLCELLULOSE AND AN OILY ACTIVE INGREDIENT | Final Rejection | NUTRITION & BIOSCIENCES USA 1, LLC |
| 18597044 | Herbicidal Compositions Comprising Fluazifop And Triclopyr | Non-Final OA | Bayer CropScience LP |
| 17903255 | HERBICIDAL COMPOSITIONS COMPRISING FLUAZIFOP, TRICLOPYR AND DIQUAT | Non-Final OA | BAYER CROPSCIENCE LP |
| 18039231 | QUICK RELEASE INSECTICIDAL COMPOSITION | Non-Final OA | UPL Limited |
| 18690286 | POROUS TITANIUM ALLOY STRUCTURE WITH A SILVER COATING HAVING OSTEOCOMPATIBILITY AND ANTIMICROBIAL PROPERTIES | Non-Final OA | WALDEMAR LINK GMBH & CO. KG |
| 18272405 | OTF COMPOUND CONNECTED BY SEWING | Final Rejection | LTS LOHMANN THERAPIE-SYSTEME AG |
| 18684555 | SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Non-Final OA | BayerAktiengesellschaft |
| 18530276 | Composite Nano-agent for Combating Drug-fast Bacteria and Preparation Method Thereof | Non-Final OA | Guangdong Medical University |
| 18563204 | STABLE LIQUID PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO | Non-Final OA | CERECIN INC. |
| 18562719 | MPLA COMPOSITIONS AND METHODS OF USE | Non-Final OA | Revelation Biosciences, Inc. |
| 18382741 | TOPICAL ANTISEPTIC | Final Rejection | SurgiWipe LLC |
| 18554605 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Non-Final OA | ANANDA SCIENTIFIC, INC. |
| 18284085 | AGRICULTURAL FORMULATIONS | Final Rejection | Stepan Company |
| 18549878 | Topical Cannabinoid Compositions and Methods for Treating Skin Diseases | Final Rejection | Avicanna Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy